Depressed patients' perspectives of 2 measures of outcome: The Quick Inventory of Depressive Symptomatology (QIDS) and the Remission from Depression Questionnaire (RDQ)

Annals of Clinical Psychiatry

Volumn 23, Issue 3, 2011, Pages 208-212

  Zimmerman, Mark ^a   Galione, Janine N ^a   Attiullah, Naureen ^a   Friedman, Michael ^a   Toba, Cristina ^a   Boerescu, Daniela A ^a   Ragheb, Moataz ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Assessment; Depression; Outcome; Remission; Remission from Depression Questionnaire (RDQ)

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT PREFERENCE; PRIORITY JOURNAL; QUESTIONNAIRE; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; RATING SCALE; REMISSION; REMISSION FROM DEPRESSION QUESTIONNAIRE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; ADOLESCENT; COMPARATIVE STUDY; DEPRESSION; MIDDLE AGED; PATIENT PARTICIPATION; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; STANDARD; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PATIENT PREFERENCE; PSYCHOMETRICS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84855602076     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. St. Louis EK. Minimizing AED adverse effects: Improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol. 2009;7:106-114.
2. Cologno D, Torelli P, Manzoni GC. Possible predictive factors in the prognosis of migraine with aura. Cephalalgia. 1999;19:824-830.
3. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992. (Pubitemid 38296854)
4. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003;289:3152-3160. (Pubitemid 37432891)
5. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841-1853.
6. Cuffel B, Azocar F, Tomlin M, et al. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry. 2003;64:397-402. (Pubitemid 36547281)
7. Shelton RC, Tomarken AJ. Can recovery from depression be achieved? Psychiatr Serv. 2001;52:1469-1478. (Pubitemid 33029585)
8. Practice guideline for the treatment of patients with major depressive disorder (revision). Washington, DC: American Psychiatric Association; 2000.
9. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2000;14:3-20. (Pubitemid 30156533)
10. Stahl S. Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy. J Clin Psychiatry. 1999;60:213-214. (Pubitemid 29193916)
11. Thase ME. Defining remission in patients treated with antidepressants. J Clin Psychiatry. 1999;60(suppl 22):3-6,35-36.
12. Faravelli C, Ambonetti A, Pallanti S, et al. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry. 1986;143:888-891. (Pubitemid 16090397)
13. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25:1171-1180.
14. Simons AD, Murphy GE, Levine JL. Relapse after treatment with cognitive therapy and/or pharmacotherapy: results after one year. Arch Gen Psychiatry. 1986;43:43-48. (Pubitemid 16148970)
15. Everson SA, Robert RE, Goldberg DE, et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133-1138. (Pubitemid 28242319)
16. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord. 1997;45:5-18. (Pubitemid 27357459)
17. Murphy J, Monson R, Olivier D, et al. Affective disorders and mortality. A general population study. Arch Gen Psychiatry. 1987;44:473-480. (Pubitemid 17064492)
18. Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38:199-205. (Pubitemid 32613851)
19. Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry. 1998;59:608-619. (Pubitemid 28555422)
20. Wells KB, Stewart A, Hayes RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914-919. (Pubitemid 19208948)
21. Zimmerman M, McGlinchey JB, Posternak MA, et al. How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry. 2006;163:148-150. (Pubitemid 43050117)
22. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573-583. (Pubitemid 37289444)
23. Trivedi MH, Rush AJ, Wisniewski SR, et al, and the STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
24. Zimmerman M, McGlinchey JB, Posternak MA, et al. Remission in depressed patients: more than just symptom resolution. J Psychiatr Res. 2008;42:797-801. (Pubitemid 351787737)
25. Gilbody S, House A, Sheldon T. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry. 2002;180:101-103. (Pubitemid 34142777)
26. Zimmerman M, McGlinchey JB. Why don't psychiatrists use scales to measure outcome when treating depressed patients? J Clin Psychiatry. 2008; 69:1916-1919.
27. Zimmerman M, McGlinchey JB, Chelminski I. An inadequate community standard of care: lack of measurement of outcome when treating depression in clinical practice. Prim psychiatry. 2008;15:67-75. (Pubitemid 351847591)
28. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology. 2007;32:2479-2489. (Pubitemid 350126843)